Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
Herald
Nicole
N
United Therapeutics Corporation, Research Triangle Park, North Carolina 27709, USA.
Laliberte
Kevin
K
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004348:Drug Labeling; D011464:Epoprostenol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000188:drug therapy*; D016247:Information Storage and Retrieval / Q000379:methods; D007262:Infusions, Intravenous; D012720:Severity of Illness Index
D000959:Antihypertensive Agents; D011464:Epoprostenol; C427248:treprostinil